BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 31435927)

  • 1. Targeted siRNA Delivery Using Lipid Nanoparticles.
    Jorge A; Pais A; Vitorino C
    Methods Mol Biol; 2020; 2059():259-283. PubMed ID: 31435927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of PLGA-Lipid Hybrid Nanoparticles for siRNA Delivery Using the Emulsion Method PLGA-PEG-Lipid Nanoparticles for siRNA Delivery.
    Wang L; Griffel B; Xu X
    Methods Mol Biol; 2017; 1632():231-240. PubMed ID: 28730443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges.
    Gomes-da-Silva LC; Fonseca NA; Moura V; Pedroso de Lima MC; Simões S; Moreira JN
    Acc Chem Res; 2012 Jul; 45(7):1163-71. PubMed ID: 22568781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid nanoparticles for short interfering RNA delivery.
    Leung AK; Tam YY; Cullis PR
    Adv Genet; 2014; 88():71-110. PubMed ID: 25409604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid-based nanoparticles in the systemic delivery of siRNA.
    Lin Q; Chen J; Zhang Z; Zheng G
    Nanomedicine (Lond); 2014 Jan; 9(1):105-20. PubMed ID: 24354813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifunctional, self-assembling anionic peptide-lipid nanocomplexes for targeted siRNA delivery.
    Tagalakis AD; Lee DH; Bienemann AS; Zhou H; Munye MM; Saraiva L; McCarthy D; Du Z; Vink CA; Maeshima R; White EA; Gustafsson K; Hart SL
    Biomaterials; 2014 Sep; 35(29):8406-15. PubMed ID: 24985735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid and Polymer-Based Nanoparticle siRNA Delivery Systems for Cancer Therapy.
    Mainini F; Eccles MR
    Molecules; 2020 Jun; 25(11):. PubMed ID: 32532030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. pH-labile PEGylation of siRNA-loaded lipid nanoparticle improves active targeting and gene silencing activity in hepatocytes.
    Hashiba K; Sato Y; Harashima H
    J Control Release; 2017 Sep; 262():239-246. PubMed ID: 28774839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesteryl oleate-loaded cationic solid lipid nanoparticles as carriers for efficient gene-silencing therapy.
    Suñé-Pou M; Prieto-Sánchez S; El Yousfi Y; Boyero-Corral S; Nardi-Ricart A; Nofrerias-Roig I; Pérez-Lozano P; García-Montoya E; Miñarro-Carmona M; Ticó JR; Suñé-Negre JM; Hernández-Munain C; Suñé C
    Int J Nanomedicine; 2018; 13():3223-3233. PubMed ID: 29881274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo delivery of RNAi with lipid-based nanoparticles.
    Huang L; Liu Y
    Annu Rev Biomed Eng; 2011 Aug; 13():507-30. PubMed ID: 21639780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive update of siRNA delivery design strategies for targeted and effective gene silencing in gene therapy and other applications.
    Abosalha AK; Ahmad W; Boyajian J; Islam P; Ghebretatios M; Schaly S; Thareja R; Arora K; Prakash S
    Expert Opin Drug Discov; 2023 Feb; 18(2):149-161. PubMed ID: 36514963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic delivery of siRNA by T7 peptide modified core-shell nanoparticles for targeted therapy of breast cancer.
    Yu MZ; Pang WH; Yang T; Wang JC; Wei L; Qiu C; Wu YF; Liu WZ; Wei W; Guo XY; Zhang Q
    Eur J Pharm Sci; 2016 Sep; 92():39-48. PubMed ID: 27355138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimized polyethylenimine (PEI)-based nanoparticles for siRNA delivery, analyzed in vitro and in an ex vivo tumor tissue slice culture model.
    Ewe A; Höbel S; Heine C; Merz L; Kallendrusch S; Bechmann I; Merz F; Franke H; Aigner A
    Drug Deliv Transl Res; 2017 Apr; 7(2):206-216. PubMed ID: 27334279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipidic systems for in vivo siRNA delivery.
    Wu SY; McMillan NA
    AAPS J; 2009 Dec; 11(4):639-52. PubMed ID: 19757082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic delivery of siRNA with cationic lipid assisted PEG-PLA nanoparticles for cancer therapy.
    Yang XZ; Dou S; Sun TM; Mao CQ; Wang HX; Wang J
    J Control Release; 2011 Dec; 156(2):203-11. PubMed ID: 21839126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrophobic Domain Structure of Linear-Dendritic Poly(ethylene glycol) Lipids Affects RNA Delivery of Lipid Nanoparticles.
    Zhou K; Johnson LT; Xiong H; Barrios S; Minnig JT; Yan Y; Abram B; Yu X; Siegwart DJ
    Mol Pharm; 2020 May; 17(5):1575-1585. PubMed ID: 32267707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermo-sensitive nanoparticles for triggered release of siRNA.
    Yang Z; Cheng Q; Jiang Q; Deng L; Liang Z; Dong A
    J Biomater Sci Polym Ed; 2015; 26(4):264-76. PubMed ID: 25566877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
    Li TS; Yawata T; Honke K
    Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multifunctional pH-Sensitive Amino Lipids for siRNA Delivery.
    Gujrati M; Vaidya A; Lu ZR
    Bioconjug Chem; 2016 Jan; 27(1):19-35. PubMed ID: 26629982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide-based targeted polymeric nanoparticles for siRNA delivery.
    Hussein WM; Cheong YS; Liu C; Liu G; Begum AA; Attallah MA; Moyle PM; Torchilin VP; Smith R; Toth I
    Nanotechnology; 2019 Oct; 30(41):415604. PubMed ID: 31295734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.